Beranda › Kanker (semua jenis) › Alabama
Uji klinis Kanker (semua jenis) di Alabama
36 studi untuk Kanker (semua jenis) mencari peserta di lokasi di Alabama.
Kota di Alabama
Teks studi resmi (Bahasa Inggris)
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- The Kirklin Clinic of UAB Hospital, Birmingham
- The University of Alabama at Birmingham, Birmingham
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06989437A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- UAB Medicine - UAB Hospital, Birmingham
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06901531Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 16, Birmingham
Menerima pesertaFase 3
Usia 18 hingga 71 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07504458A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Birmingham Hematology and Oncology Associates d/b/a Alabama Oncology /ID# 280063, Birmingham
- Usa Mitchell Cancer Institute /ID# 280198, Mobile
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07365241TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham
Menerima pesertaFase 2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT02693535Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- University of Alabama Birmingham, Birmingham
Menerima pesertaFase 2/3
Semua usia · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT03435796RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- UAB, Psychiatry and Behavioral Neurology, Birmingham
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07002034A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
- The University of Alabama at Birmingham ( Site 1005), Birmingham
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06818643A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Clearview Cancer Institute, Huntsville
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06119581HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- University of Alabama at Birmingham Cancer Center, Birmingham
Menerima pesertaFase 1
36 Months – 22 Years · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT03911388Project: Every Child for Younger Patients With Cancer
- Children's Hospital of Alabama, Birmingham
- USA Health Strada Patient Care Center, Mobile
Menerima pesertaStudi observasional
Hingga usia 25 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT02402244A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
- Childrens Hospital of Alabama, Birmingham
Menerima pesertaFase 2
Usia 1 hingga 39 · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT05999994Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- University of Alabama at Birmingham Cancer Center, Birmingham
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT06580314Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
- 004, Birmingham
Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 16 Jul 2026 · NCT06906341A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- Clearview Cancer Institute - Huntsville - Cci Drive /ID# 278621, Huntsville
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jul 2026 · NCT07023289A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
- University of Alabama at Birmingham, Birmingham
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jul 2026 · NCT06997029A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
- University of Alabama at Birmingham, Division of Hematology and Oncology, Birmingham
Menerima peserta
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT06697600A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
- GSK Investigational Site, Birmingham
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Jun 2026 · NCT06431594Childhood Cancer Survivor Study
- University of Alabama at Birmingham/Children's of Alabama, Birmingham
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Semua usia · Semua jenis kelamin · Diperbarui 17 Jun 2026 · NCT01120353Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
- Birmingham VA Medical Center, Birmingham, AL, Birmingham
Menerima peserta
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 17 Jun 2026 · NCT05486572Multisite Implementation of COMPRENDO
- Children's of Alabama/University of Alabama at Birmingham, Birmingham
Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Jun 2026 · NCT06055296Leading Healthy Eating and Activity Promotion Program
- University of Alabama at Birmingham, Birmingham
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 89 · Semua jenis kelamin · Diperbarui 19 Mei 2026 · NCT06868524Video Inspired Discussions About Ethical Outcomes in Pediatrics
- Children's of Alabama at Birmingham, Birmingham
Menerima peserta
Semua usia · Semua jenis kelamin · Diperbarui 14 Mei 2026 · NCT06786104I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
- University of Alabama at Birmingham, Birmingham
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Mei 2026 · NCT01042379Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- University of Alabama at Birmingham, Birmingham
- University of South Alabama, Mobile
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Apr 2026 · NCT05297734Evaluating the Implementation and Impact of Standard-of-care Delivered Oncology Financial Navigation
- University of Alabama at Birmingham, Birmingham
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Feb 2026 · NCT07281287TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
- Alabama Oncology, Birmingham
Menerima pesertaStudi observasional
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 24 Feb 2026 · NCT06207032Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
- The Kirklin Clinic, Birmingham
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Feb 2026 · NCT07197515GEMINI-NSCLC: NSCLC Biomarker Study
- Alabama Oncology, Birmingham
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Feb 2026 · NCT05236114Caris Biorepository Research Protocol
- University of South Alabama, Mobile
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Jan 2026 · NCT01499394SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Birmingham
- Massive Bio SYNERGY-AI site, Mobile
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
- XCancer Research Network/Dothan Hematology & Oncology, Dothan
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Okt 2025 · NCT06228326BMT-CARE: Psychosocial Intervention for Transplant Caregivers
- University of Alabama at Brimingham, Birmingham
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Okt 2025 · NCT06472089Making Healthy Habits Stick
- University of Alabama at Birmingham, Birmingham
Menerima peserta
Usia 19 ke atas · Wanita · Diperbarui 1 Okt 2025 · NCT06745180Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- University of South Alabama Mitchell Cancer Institute, Mobile
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Nov 2024 · NCT03860883Collection and Distribution of Biospecimens for Novel Research Uses
- iSpecimen, Huntsville
Menerima pesertaStudi observasionalSukarelawan sehat diterima
1 Month – 89 Years · Semua jenis kelamin · Diperbarui 9 Nov 2022 · NCT03848962Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.